Shareprice
16 Jan 2025

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

Presentation of FluoGuide at Life Science Investorkonference Q3 2019

News


September 20, 2019

FluoGuide A/S ("FluoGuide", ticker FLUO) was presented at the 18 September at the Life Science Investorkonference in Copenhagen, a conference where other life science companies presented their businesses and future plans. The presentation from FluoGuide is now available at FluoGuide’s home page (www.fluoguide.com) and a video will also be made available on FluoGuide’s home page as soon as available. 

FluoGuide will present next time in Stockholm, on 18 November 2019 at the Sedemeradagen.


For further information about FluoGuide, please contact:
Morten Albrechtsen, CEO
M: +45 24 25 62 66
ma@fluoguide.com

Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
Save Accept all